NVRO Nevro Corp

Price (delayed)

$45.97

Market cap

$1.62B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.9

Enterprise value

$1.77B

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
NVRO's quick ratio has surged by 111% year-on-year and by 4.6% since the previous quarter
The revenue has grown by 6% YoY
The debt is down by 39% year-on-year but it is up by 20% since the previous quarter
The net income has plunged by 55% YoY and by 3.6% from the previous quarter
The EPS has dropped by 53% year-on-year and by 3.4% since the previous quarter

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
35.26M
Market cap
$1.62B
Enterprise value
$1.77B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.7
Price to sales (P/S)
4.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.59
Earnings
Revenue
$386.14M
EBIT
-$120.95M
EBITDA
-$111.75M
Free cash flow
-$74.82M
Per share
EPS
-$3.9
Free cash flow per share
-$2.13
Book value per share
$6.86
Revenue per share
$11.01
TBVPS
$15.19
Balance sheet
Total assets
$532.88M
Total liabilities
$292.49M
Debt
$200.14M
Equity
$240.39M
Working capital
$420.06M
Liquidity
Debt to equity
0.83
Current ratio
6.97
Quick ratio
5.51
Net debt/EBITDA
-1.34
Margins
EBITDA margin
-28.9%
Gross margin
68.1%
Net margin
-35.3%
Operating margin
-31.4%
Efficiency
Return on assets
-23.8%
Return on equity
-44.6%
Return on invested capital
-20.4%
Return on capital employed
-26.1%
Return on sales
-31.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
-0.88%
1 week
6.26%
1 month
5.99%
1 year
-72.23%
YTD
-43.3%
QTD
-36.44%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$386.14M
Gross profit
$262.84M
Operating income
-$121.19M
Net income
-$136.12M
Gross margin
68.1%
Net margin
-35.3%
NVRO's operating income has shrunk by 95% YoY and by 9% QoQ
The operating margin has plunged by 83% YoY and by 9% from the previous quarter
The net income has plunged by 55% YoY and by 3.6% from the previous quarter
The net margin is down by 46% year-on-year and by 3.8% since the previous quarter

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
6.7
P/S
4.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.59
The EPS has dropped by 53% year-on-year and by 3.4% since the previous quarter
NVRO's P/B is 45% below its last 4 quarters average of 12.2 and 40% below its 5-year quarterly average of 11.2
The equity has contracted by 34% YoY and by 21% from the previous quarter
The P/S is 56% lower than the last 4 quarters average of 9.6 and 51% lower than the 5-year quarterly average of 8.6
The revenue has grown by 6% YoY

Efficiency

How efficient is Nevro business performance
The company's return on invested capital has shrunk by 143% YoY and by 16% QoQ
The ROA has plunged by 111% YoY and by 14% from the previous quarter
NVRO's return on equity has dropped by 91% year-on-year and by 14% since the previous quarter
The return on sales has dropped by 85% year-on-year and by 9% since the previous quarter

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 82% greater than its total liabilities
Nevro's current ratio has surged by 132% YoY and by 8% QoQ
NVRO's quick ratio has surged by 111% year-on-year and by 4.6% since the previous quarter
The debt is 17% smaller than the equity
The debt to equity has soared by 51% QoQ but it has decreased by 8% YoY
The debt is down by 39% year-on-year but it is up by 20% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.